Multivitamins Show No Link To 'Lower Risk of Death,' Study Finds

Taking a multivitamin once a day has long been considered a path to better health, but a new study refutes that widely held belief.

A study published in JAMA Network Open on Wednesday revealed that after tracking nearly 400,000 healthy adults for over 20 years, researchers found no link between regular multivitamin use and a lower risk of death, according to the National Institutes of Health.

The study was led by researchers at the National Institutes of Health's National Cancer Institute.

Also Read: Healthcare Advocates United: A Push For Congress To Recognize CBD As Dietary Supplements

“The analysis showed that people who took daily multivitamins did not have a lower risk of death from any cause than people who took no multivitamins,” Erikka Loftfield, Ph.D., M.P.H., a researcher with the division of cancer epidemiology and genetics at the National Cancer Institute, wrote in the study.

“There were also no differences in mortality from cancer, heart disease, or cerebrovascular diseases. The results were adjusted for factors such as race and ethnicity, education, and diet quality.”

Loftfield also emphasized the importance of assessing the risk of death associated with multivitamin use in different populations, such as those with documented nutritional deficiencies. She highlighted the need to explore the potential impact of regular multivitamin use on aging-related health conditions.

Price Action: Despite the study’s findings on multivitamin use, related health and wellness companies saw varied market reactions. By Thursday’s afternoon trading, BellRing Brands, Inc. BRBR gained 1.08% to $57.89, Herbalife Ltd. HLF slipped 1.03% to $10.52, and USANA Health Sciences, Inc. USNA was up 1% to $45.44.

Invesco S&P SmallCap Consumer Staples ETF PSCC slipped 0.09% by early afternoon, while VegTech Plant-based Innovation & Climate ETF EATV remained unchanged and Invesco Food & Beverage ETF PBJ declined 0.68%.

Read Next: